|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heiden MG Vander, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park MJ, Lee WJ, Lim HK, Park KW, Choi JY
and Kim BT: Detecting recurrence of gastric cancer: The value of
FDG PET/CT. Abdom Imaging. 34:441–447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weber WA and Wieder H: Monitoring
chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol
Imaging. 33 Suppl 1:S27–S37. 2006. View Article : Google Scholar
|
|
6
|
Najafov A and Alessi DR: Uncoupling the
Warburg effect from cancer. Proc Natl Acad Sci USA. 107:pp.
19135–19136. 2010; View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao Y, Butler EB and Tan M: Targeting
cellular metabolism to improve cancer therapeutics. Cell Death Dis.
4:e5322013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pedersen PL: Warburg, me and Hexokinase 2:
Multiple discoveries of key molecular events underlying one of
cancers' most common phenotypes, the ‘Warburg Effect’, i.e.,
elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr.
39:211–222. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang TA, Zhang XD, Guo XY, Xian SL and Lu
YF: 3-Bromopyruvate and sodium citrate target glycolysis, suppress
survivin, and induce mitochondrial-mediated apoptosis in gastric
cancer cells and inhibit gastric orthotopic transplantation tumor
growth. Oncol Rep. 35:1287–1296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kruspig B, Nilchian A, Orrenius S,
Zhivotovsky B and Gogvadze V: Citrate kills tumor cells through
activation of apical caspases. Cell Mol Life Sci. 69:4229–4237.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lincet H, Kafara P, Giffard F,
Abeilard-Lemoisson E, Duval M, Louis MH, Poulain L and Icard P:
Inhibition of Mcl-1 expression by citrate enhances the effect of
Bcl-xL inhibitors on human ovarian carcinoma cells. J Ovarian Res.
6:722013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Halabe Bucay A: Hypothesis
proved&citric acid (citrate) does improve cancer: A case of a
patient suffering from medullary thyroid cancer. Med Hypotheses.
73:2712009. View Article : Google Scholar
|
|
13
|
Lu Y, Zhang X, Zhang H, Lan J, Huang G,
Varin E, Lincet H, Poulain L and Icard P: Citrate induces apoptotic
cell death: A promising way to treat gastric carcinoma? Anticancer
Res. 31:797–805. 2011.PubMed/NCBI
|
|
14
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fulda S and Debatin KM: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Slee EA, Adrain C and Martin SJ:
Executioner caspase-3, −6, and −7 perform distinct, non-redundant
roles during the demolition phase of apoptosis. J Biol Chem.
276:7320–7326. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Taylor RC, Cullen SP and Martin SJ:
Apoptosis: Controlled demolition at the cellular level. Nat Rev Mol
Cell Biol. 9:231–241. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mita AC, Mita MM, Nawrocki ST and Giles
FJ: Survivin: Key regulator of mitosis and apoptosis and novel
target for cancer therapeutics. Clin Cancer Res. 14:5000–5005.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC,
Hwang JI, Chung CW, Jung YK and Oh BH: An anti-apoptotic protein
human survivin is a direct inhibitor of caspase-3 and −7.
Biochemistry. 40:1117–1123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tamm I, Wang Y, Sausville E, Scudiero DA,
Vigna N, Oltersdorf T and Reed JC: IAP-family protein survivin
inhibits caspase activity and apoptosis induced by Fas (CD95), Bax,
caspases, and anticancer drugs. Cancer Res. 58:5315–5320.
1998.PubMed/NCBI
|
|
22
|
Orrenius S, Gogvadze V and Zhivotovsky B:
Mitochondrial oxidative stress: Implications for cell death. Annu
Rev Pharmacol Toxicol. 47:143–183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
ille EA Sausv and Burger AM: Contributions
of human tumor xenografts to anti cancer drug development. Cancer
Res. 66:3351–3354. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Johnson JI, Decker S, Zaharevitz D,
Rubinstein LV, Venditti JM, Schepartz S, Kalyandrug S, Christian M,
Arbuck S, Hollingshead M, et al: Relationships between drug
activity in NCI preclinical in vitro and in vivo models and early
clinical trials. Br J Cancer. 84:1424–1431. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bibby MC: Orthotopic models of cancer for
preclinical drug evaluation: Advantages and disadvantages. Eur J
Cancer. 40:852–857. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Solaini G, Sgarbi G and Baracca A:
Oxidative phosphorylation in cancer cells. Biochim Biophys Acta.
1807:534–542. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bonnet S, Archer SL, Allalunis-Turner J,
Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta
L, Bonnet S, et al: A mitochondria-K+ channel axis is suppressed in
cancer and its normalization promotes apoptosis and inhibits cancer
growth. Cancer Cell. 11:37–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh D, Banerji AK, Dwarakanath BS,
Tripathi RP, Gupta JP, Mathew TL, Ravindranath T and Jain V:
Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose
escalation studies in patients with glioblastoma multiforme.
Strahlenther Onkol. 181:507–514. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fahim FA, Esmat AY, Mady EA and Ibrahim
EK: Antitumor activities of iodoacetate and dimethylsulphoxide
against solid Ehrlich carcinoma growth in mice. Biol Res.
36:253–262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Buerkle A and Weber WA: Imaging of tumor
glucose utilization with positron emission tomography. Cancer
Metastasis Rev. 27:545–554. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bradbury MS, Hambardzumyan D, Zanzonico
PB, Schwartz J, Cai S, Burnazi EM, Longo V, Larson SM and Holland
EC: Dynamic small-animal PET imaging of tumor proliferation with
3′-deoxy-3′-18F-fluorothymidine in a genetically engineered mouse
model of high-grade gliomas. J Nucl Med. 49:422–429. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Walter MA, Hildebrandt IJ, Hacke K, Kesner
AL, Kelly O, Lawson GW, Phelps ME, Czernin J, Weber WA and Schiestl
RH: Small-animal PET/CT for monitoring the development and response
to chemotherapy of thymic lymphoma in Trp53-/- mice. J Nucl Med.
51:1285–1292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Talib WH and Mahasneh AM:
Antiproliferative activity of plant extracts used against cancer in
traditional medicine. Sci Pharm. 78:33–45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Launay S, Hermine O, Fontenay M, Kroemer
G, Solary E and Garrido C: Vital functions for lethal caspases.
Oncogene. 24:5137–5148. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gupta S, Yel L, Kim D, Kim C, Chiplunkar S
and Gollapudi S: Arsenic trioxide induces apoptosis in peripheral
blood T lymphocyte subsets by inducing oxidative stress: A role of
Bcl-2. Mol Cancer Ther. 2:711–719. 2003.PubMed/NCBI
|
|
36
|
Fan TJ, Han LH, Cong RS and Liang J:
Caspase family proteases and apoptosis. Acta Biochim Biophys Sin.
37:719–727. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Church DN and Talbot DC: Survivin in solid
tumors: Rationale for development of inhibitors. Curr Oncol Rep.
14:120–128. 2012. View Article : Google Scholar : PubMed/NCBI
|
